RxDoctor Payments Data

Saurav Haldar, MD

Medical Oncology · Houston, TXNPI 1023506995

Payments from drug & device makers

$108,127in general payments, 2019–2025

Across 6 payments — averaging $18,021 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$108K
  • Exelixis Inc.$174
  • Shionogi Inc$124
  • Jazz Pharmaceuticals Inc.$97
  • Genentech USA, Inc.$92

What the payments were for

  • Food & beverage$487100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$108,127 in reported general payments places this provider in the 55th percentile of 495 medical oncology providers in Texas.

See all medical oncology providers in Texas

Medicare billing

Part B allowed, 2024
$7,949
Medicare patients
43
Services billed
63

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical oncology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →